» Articles » PMID: 22412006

A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology

Overview
Journal Ann Fam Med
Specialty Public Health
Date 2012 Mar 14
PMID 22412006
Citations 518
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We sought to identify and compare studies reporting the prevalence of multimorbidity and to suggest methodologic aspects to be considered in the conduct of such studies.

Methods: We searched the literature for English- and French-language articles published between 1980 and September 2010 that described the prevalence of multimorbidity in the general population, in primary care, or both. We assessed quality of included studies with a modified version of the Strengthening the Reporting of Observational Studies in Epidemiology checklist. Results of individual prevalence studies were adjusted so that they could be compared graphically.

Results: The final sample included 21 articles: 8 described studies conducted in primary care, 12 in the general population, and 1 in both. All articles were of good quality. The largest differences in prevalence of multimorbidity were observed at age 75 in both primary care (with prevalence ranging from 3.5% to 98.5% across studies) and the general population (with prevalence ranging from 13.1% to 71.8% across studies). Apart from differences in geographic settings, we identified differences in recruitment method and sample size (primary care: 980-60,857 patients; general population: 1,099-316,928 individuals), data collection, and the operational definition of multimorbidity used, including the number of diagnoses considered (primary care: 5 to all; general population: 7 to all). This last aspect seemed to be the most important factor in estimating prevalence.

Conclusions: Marked variation exists among studies of the prevalence of multimorbidity with respect to both methodology and findings. When undertaking such studies, investigators should carefully consider the specific diagnoses included and their number, as well as the operational definition of multimorbidity.

Citing Articles

Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities.

Cruz-Santiago D, Meng X, Canac-Marquis M, Sengupta A, Brassard J, Pavey E Can Geriatr J. 2025; 28(1):67-72.

PMID: 40051588 PMC: 11882206. DOI: 10.5770/cgj.28.770.


Perceived Connections Between Personal Values and Health in High-Risk Patients with Multimorbidity: A Qualitative Study.

Schuttner L, Staloff J, Theis M, Ralston J, Rosland A, Nelson K J Gen Intern Med. 2025; .

PMID: 40038223 DOI: 10.1007/s11606-025-09448-z.


Examining the association of psychosocial and health behaviors with life satisfaction among canadians: a nationally representative study.

Geda N, Cahill L, Feng C Arch Public Health. 2025; 83(1):51.

PMID: 39994793 PMC: 11849353. DOI: 10.1186/s13690-025-01502-w.


Multimorbidity and associated factors in the adult Indigenous population living in villages in the municipality of Aracruz, Espírito Santo, State, Brazil.

Santos H, Mill J Cad Saude Publica. 2025; 40(12):e00135323.

PMID: 39936744 PMC: 11805521. DOI: 10.1590/0102-311XEN135323.


Effectiveness of interactive dashboards to optimise prescribing in primary care: a protocol for a systematic review.

Moynagh P, Mannion A, Wei A, Clyne B, Moriarty F, McCarthy C HRB Open Res. 2025; 7:44.

PMID: 39931386 PMC: 11808840. DOI: 10.12688/hrbopenres.13909.1.


References
1.
Schram M, Frijters D, van de Lisdonk E, Ploemacher J, de Craen A, de Waal M . Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly. J Clin Epidemiol. 2008; 61(11):1104-12. DOI: 10.1016/j.jclinepi.2007.11.021. View

2.
Uijen A, van de Lisdonk E . Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract. 2008; 14 Suppl 1:28-32. DOI: 10.1080/13814780802436093. View

3.
Nagel G, Peter R, Braig S, Hermann S, Rohrmann S, Linseisen J . The impact of education on risk factors and the occurrence of multimorbidity in the EPIC-Heidelberg cohort. BMC Public Health. 2008; 8:384. PMC: 2614432. DOI: 10.1186/1471-2458-8-384. View

4.
Loza E, Jover J, Rodriguez L, Carmona L . Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Semin Arthritis Rheum. 2008; 38(4):312-9. DOI: 10.1016/j.semarthrit.2008.01.004. View

5.
Starfield B . Challenges to primary care from co- and multi-morbidity. Prim Health Care Res Dev. 2011; 12(1):1-2. DOI: 10.1017/S1463423610000484. View